A comparison of Val81Met and other polymorphisms of alcohol metabolising genes in patients and controls in Northern Spain

Alcohol

Volumn 46, Issue 5, 2012, Pages 427-431

  Celorrio, David ^a   Bujanda, Luis ^a   Caso, Carlos ^b   Landabaso, Miguel ^c   Oria, Juan Carlos ^d   Ogando, Javier ^e   de Pancorbo, Marian M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Servicio de Alcoholismo y Ludopatías de álava   (Spain)

^c Unidad de Toxicomanias del Centro de Salud Mental Uribe Getxo   (Spain)

^d Unidad de Patología Crónica Compleja Servicio de Pediatría y Áreas Específicas Hospital Universitario de Navarra Servicio Navarro de Salud Osasunbidea   (Spain)

^e Jefe de Unidad de Salud Mental Red de Salud Mental Bizkaia   (Spain)

Author keywords

ADH1B; ADH1C; Alcohol; Alcoholism; ALDH2; Basque Country; CYP2E1; Genetic; Polymorphism; Risk factor; SNP; TH

Indexed keywords

ALCOHOL DEHYDROGENASE; ALCOHOL DEHYDROGENASE 1B; ALCOHOL DEHYDROGENASE 1C; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CYTOCHROME P450 2E1; METHIONINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VALINE;

ALCOHOL METABOLISING GENE; ALCOHOL METABOLISM; ALCOHOL USE DISORDER; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; ALCOHOL DEHYDROGENASE; ALCOHOLISM; CYTOCHROME P-450 CYP2E1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPAIN; TYROSINE 3-MONOOXYGENASE;

EID: 84863106940     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2012.03.003     Document Type: Article

References (48)

1. Anney R.J., Olsson C.A., Lotfi-Miri M., Patton G.C., Williamson R. Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism. Pharmacogenetics 2004, 14:73-81.
2. Benmoyal-Segal L., Soreq H. Gene-environment interactions in sporadic Parkinson's disease. Journal of Neurochemistry 2006, 97:1740-1755.
3. Borras E., Coutelle C., Rosell A., Fernandez-Muixi F., Broch M., Crosas B., et al. Genetic polymorphism of alcohol dehydrogenase in Europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 2000, 31:984-989.
4. Celorrio D., Bujanda L., Chbel F., Sanchez D., Martinez-Jarreta B., de Pancorbo M.M. Alcohol-metabolizing enzyme gene polymorphisms in the Basque Country, Morocco, and Ecuador. Alcoholism: Clinical & Experimental Research 2011, 35(5):879-884.
5. Chao Y.C., Liou S.R., Chung Y.Y., Tang H.S., Hsu C.T., Li T.K., et al. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 1994, 19:360-366.
6. Chen C.C., Lu R.B., Chen Y.C., Wang M.F., Chang Y.C., Li T.K., et al. Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. American Journal of Human Genetics 1999, 65:795-807.
7. Crabb D.W., Edenberg H.J., Bosron W.F., Li T.K. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. Journal of Clinical Investigation 1989, 83:314-316.
8. Crabb D.W., Matsumoto M., Chang D., You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proceedings of the Nutrition Society 2004, 63:49-63.
9. Dahmen N., Volp M., Singer P., Hiemke C., Szegedi A. Tyrosine hydroxylase Val-81-Met polymorphism associated with early-onset alcoholism. Psychiatric Genetics 2005, 15:13-16.
10. Dick D.M., Foroud T. Candidate genes for alcohol dependence: a review of genetic evidence from human studies. Alcoholism: Clinical & Experimental Research 2003, 27:868-879.
11. Fernandez V., Massa L., Quinones L., Simon-Giavarotti K.A., Giavarotti L., D'Almeida V., et al. Effects of gamma-hexachlorocyclohexane and L-3,3',5-triiodothyronine on rat liver cytochrome P4502E1-dependent activity and content in relation to microsomal superoxide radical generation. Biological Research 2003, 36:359-365.
12. Gemma S., Vichi S., Testai E. Individual susceptibility and alcohol effects: biochemical and genetic aspects. Annali dell'Istituto Superiore di Sanità 2006, 42:8-16.
13. Goedde H.W., Agarwal D.P., Fritze G., Meier-Tackmann D., Singh S., Beckmann G., et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Human Genetics 1992, 88:344-346.
14. Gordillo-Bastidas E., Panduro A., Gordillo-Bastidas D., Zepeda-Carrillo E.A., Garcia-Banuelos J.J., Munoz-Valle J.F., et al. Polymorphisms of alcohol metabolizing enzymes in indigenous Mexican population: unusual high frequency of CYP2E1*c2 allele. Alcoholism: Clinical & Experimental Research 2009, 34:142-149.
15. Gorwood P. Contribution of genetics to the concept of risk status for alcohol dependence. Journal de la Societe de biologie 2000, 194:43-49.
16. Grove J., Brown A.S., Daly A.K., Bassendine M.F., James O.F., Day C.P. The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 1998, 8:335-342.
17. Haufroid V., Buchet J.P., Gardinal S., Lison D. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. International Archives of Occupational and Environmental Health 2002, 75:453-458.
18. Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. Journal of Biochemistry 1991, 110:559-565.
19. Hsu L.C., Tani K., Fujiyoshi T., Kurachi K., Yoshida A. Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proceedings of the National Academy of Sciences USA 1985, 82:3771-3775.
20. Hu Y., Oscarson M., Johansson I., Yue Q.Y., Dahl M.L., Tabone M., et al. Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Molecular Pharmacology 1997, 51:370-376.
21. Ishiguro H., Arinami T., Saito T., Akazawa S., Enomoto M., Mitushio H., et al. Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism. American Journal of Medical Genetics 1998, 81:388-396.
22. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
23. Kumer S.C., Vrana K.E. Intricate regulation of tyrosine hydroxylase activity and gene expression. Journal of Neurochemistry 1996, 67:443-462.
24. Lee S.L., Hoog J.O., Yin S.J. Functionality of allelic variations in human alcohol dehydrogenase gene family: assessment of a functional window for protection against alcoholism. Pharmacogenetics 2004, 14:725-732.
25. Lingford-Hughes A., Nutt D. Neurobiology of addiction and implications for treatment. British Journal of Psychiatry 2003, 182:97-100.
26. Linhart A., Jindra A., Golan L., Jachymova M., Sedlacek K., Peleska J., et al. Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men. British Journal of Biomedical Science 2002, 59:90-94.
27. Lucas D., Menez C., Girre C., Berthou F., Bodenez P., Joannet I., et al. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 1995, 5:298-304.
28. Ludecke B., Bartholome K. Frequent sequence variant in the human tyrosine hydroxylase gene. Human Genetics 1995, 95:716.
29. Lumeng L., Crabb D.W. Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 1994, 107:572-578.
30. Munafo M., Johnstone E., Murphy M., Walton R. New directions in the genetic mechanisms underlying nicotine addiction. Addiction Biology 2001, 6:109-117.
31. Nagatsu T., Levitt M., Udenfriend S. Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues. Biochemical and Biophysical Research Communications 1964, 14:543-549.
32. Pagano G., Pacini G., Musso G., Gambino R., Mecca F., Depetris N., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35:367-372.
33. Raymond M., Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. Journal of Heredity 1995, 86:248-249.
34. Sun F., Tsuritani I., Yamada Y. Contribution of genetic polymorphisms in ethanol-metabolizing enzymes to problem drinking behavior in middle-aged Japanese men. Behavior Genetics 2002, 32:229-236.
35. Takahashi T., Lasker J.M., Rosman A.S., Lieber C.S. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993, 17:236-245.
36. Tanaka F., Shiratori Y., Yokosuka O., Imazeki F., Tsukada Y., Omata M. Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcoholism: Clinical & Experimental Research 1997, 21:596-601.
37. Thomasson H.R., Edenberg H.J., Crabb D.W., Mai X.L., Jerome R.E., Li T.K., et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. American Journal of Human Genetics 1991, 48:677-681.
38. Tsutsumi M., Wang J.S., Takase S., Takada A. Hepatic messenger RNA contents of cytochrome P4502E1 in patients with different P4502E1 genotypes. Alcohol and Alcoholism-Supplement 1994, 29:29-32.
39. Tupala E., Tiihonen J. Dopamine and alcoholism: neurobiological basis of ethanol abuse. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004, 28:1221-1247.
40. Ueno Y., Adachi J., Imamichi H., Nishimura A., Tatsuno Y. Effect of the cytochrome P-450IIE1 genotype on ethanol elimination rate in alcoholics and control subjects. Alcoholism: Clinical & Experimental Research 1996, 20:17A-21A.
41. Ueshima Y., Tsutsumi M., Takase S., Matsuda Y., Kawahara H. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcoholism: Clinical & Experimental Research 1996, 20:25A-28A.
42. Vidal F., Lorenzo A., Auguet T., Olona M., Broch M., Gutierrez C., et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. Journal of Hepatology 2004, 41:744-750.
43. Vodicka P., Soucek P., Tates A.D., Dusinska M., Sarmanova J., Zamecnikova M., et al. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutation Research 2001, 482:89-103.
44. Wang Z., Hall S.D., Maya J.F., Li L., Asghar A., Gorski J.C. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. British Journal of Clinical Pharmacology 2003, 55:77-85.
45. Ward R.J., McPherson A.J., Chow C., Ealing J., Sherman D.I., Yoshida A., et al. Identification and characterisation of alcohol-induced flushing in Caucasian subjects. Alcohol and Alcoholism 1994, 29:433-438.
46. Wolff P.H. Ethnic differences in alcohol sensitivity. Science 1972, 175:449-450.
47. Xu Y.L., Carr L.G., Bosron W.F., Li T.K., Edenberg H.J. Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplification. Genomics 1988, 2:209-214.
48. Zakhari S. Overview: how is alcohol metabolized by the body?. Alcohol Research & Health 2006, 29:245-254.